USPharmacist | Weekly News Update


March 11, 2015
  • Even Limited Use of NSAIDs Increases Bleeding,
    CV Events in MI Patients

    For patients recovering from myocardial infarction, combining nonsteroidal anti-inflammatory drugs with their antithrombotic therapy can be dangerous. A new study finds that the combination, even over a limited period of time, can increase risks of bleeding and cardiovascular events. Here are the details.

  • Net Worth Affects Adherence to Breast Cancer Hormonal Therapy

    Hormonal therapy for breast cancer can be pricey, and many women just stop taking the drugs if they can’t afford them. To better understand which patients are likely to adhere to therapy and which need financial help to do so, a new study argues that net worth is a better indicator than income. Find out why using that measure also helps resolve some of the racial disparities in care.

  • New Study: Pimecrolimus Use Not Linked to
    Cancer in Children

    Will a new study alleviate some of the concerns about pimecrolimus use in children with atopic dermatitis? It should, according to the researchers and an accompanying editorial. The Pediatric Eczema Elective Registry (PEER) study found no evidence that the topical medication increased cancer in a group of children followed for a decade.

  • After Ending Tobacco Sales, CVS Focuses on
    Smoking Cessation

    After CVS Health shocked the industry by announcing a year ago that it would stop selling tobacco, the company has been focusing on smoking cessation. At the end of 2014, the pharmacy chain interacted with hundreds of thousands of customers—both in person and online—to educate them about the benefits of quitting tobacco use. Here are the details.

U.S. Pharmacist Social Connect